Mesothelioma Science News
San Pedro, CA - June 23, 2008
|
1.
|
Chemotherapy of malignant pleural mesothelioma: have we made any
progress?
Click here |
| |
|
| 2.
|
Multimodal therapy for malignant pleural mesothelioma including
extrapleural pneumonectomy
Click here |
| |
|
| 3.
|
Mesothelioma: a still current occupational cancer
Click here |
| |
|
| 4.
|
Asbestos burden predicts survival in pleural mesothelioma
Click here |
| |
|
| 5.
|
Schedule-dependent synergistic effect of pemetrexed combined with
gemcitabine against malignant pleural mesothelioma and non-small
cell lung cancer cell lines
Click here |
| |
|
| 6.
|
Measles virus induces oncolysis of mesothelioma cells and allows
dendritic cells to cross-prime tumor-specific CD8 response
Click here |
| |
|
| 7.
|
Mapping the risk of mesothelioma due to neighborhood asbestos
exposure
Click here |
| |
|
| 8.
|
Development of an exposure assessment method for epidemiological
studies of New York State personnel who responded to the World Trade
Center disaster
Click here |
| |
|
| 9.
|
Erlotinib plus bevacizumab in previously treated patients with
malignant pleural mesothelioma
Click here |
| |
|
| 10.
|
Cisplatin and vinorelbine first-line chemotherapy in non-resectable
malignant pleural mesothelioma
Click here |
| |
|
| 11.
|
Pemetrexed plus carboplatin in elderly patients with malignant
pleural mesothelioma: combined analysis of two phase II trials
Click here |
| |
|
|
PATIENT PROFILES
